Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone
Authors:
- Carl EdwardsCECarl Edwards
- Julie S. GreenJGJulie S. Green
- Hans-Dieter VolkHVHans-Dieter Volk
- Michael SchiffMSMichael Schiff
- Brian L. KotzinBKBrian L. Kotzin
- Hiroaki MitsuyaHMHiroaki Mitsuya
- Tatsuya KawaguchiTKTatsuya Kawaguchi
- John CheronisJCJohn Cheronis
- David TrollingerDTDavid Trollinger
- Danute Bankaitis-DavisDBDanute Bankaitis-Davis
Open Access
- 1 January 2012
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 3, 366
Abstract
Periodic assessment of gene expression for diagnosis and monitoring in rheumatoid arthritis (RA) may provide a readily available and useful method to detect subclinical disease progression and follow responses to therapy with disease modifying anti-rheumatic agents (DMARDs) or anti-TNF-α therapy. We used quantitative real-time PCR to compare peripheral blood gene expression profiles in active (“unstable”) RA patients on DMARDs, stable RA patients on DMARDs, and stable RA patients treated with a combination of a disease-modifying anti-rheumatoid drug (DMARD) and an anti-TNF-α agent (infliximab or etanercept) to healthy human controls. The expression of 48 inflammatory genes were compared between healthy controls (N = 122), unstable DMARD patients (N = 18), stable DMARD patients (N = 26), and stable patients on combination therapy (N = 20). Expression of 13 genes was very low or undetectable in all study groups. Compared to healthy controls, patients with unstable RA on DMARDs exhibited increased expression of 25 genes, stable DMARD patients exhibited increased expression of 14 genes and decreased expression of five genes, and combined therapy patients exhibited increased expression of six genes and decreased expression of 10 genes. These findings demonstrate that active RA is associated with increased expression of circulating inflammatory markers whereas increases in inflammatory gene expression are diminished in patients with stable disease on either DMARD or anti-TNF-α therapy. Furthermore, combination DMARD and anti-TNF-α therapy is associated with greater reductions in circulating inflammatory gene expression compared to DMARD therapy alone. These results suggest that assessment of peripheral blood gene expression may prove useful to monitor disease progression and response to therapy.Keywords
This publication has 52 references indexed in Scilit:
- Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human MelanomaPLOS ONE, 2011
- Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cellsExperimental & Molecular Medicine, 2011
- The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent mannerArthritis & Rheumatism, 2010
- Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targetsBMC Medical Genomics, 2010
- Transcriptome Analysis Describing New Immunity and Defense Genes in Peripheral Blood Mononuclear Cells of Rheumatoid Arthritis PatientsPLOS ONE, 2009
- Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsAnnals of the Rheumatic Diseases, 2007
- Tumor necrosis factor α activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid jointArthritis & Rheumatism, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988